BiotechTube

Cord Tissue Mesenchymal Stromal Cells

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Autism

Conditions

Autism, Autism Spectrum Disorder

Trial Timeline

Oct 12, 2020 → Feb 1, 2024

NCT ID
NCT04089579

About Cord Tissue Mesenchymal Stromal Cells

Cord Tissue Mesenchymal Stromal Cells is a phase 2 stage product being developed by Cryo-Cell for Autism. The current trial status is completed. This product is registered under clinical trial identifier NCT04089579. Target conditions include Autism, Autism Spectrum Disorder.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT04089579Phase 2Completed

Competing Products

20 competing products in Autism

See all competitors
ProductCompanyStageHype Score
Ketamine + PlaceboRoivant SciencesPhase 1
30
Suramin SodiumPaxMedicaPhase 2
44
NORSPAN Buprenorphine Transdermal Patchs for Very-low dose group + NORSPAN Buprenorphine Transdermal Patchs for Lower dose group + NORSPAN Buprenorphine Transdermal Patchs for higher dose groupShionogiPre-clinical
23
Lurasidone 20 mg daily + Lurasidone + PlaceboSumitomo PharmaPhase 3
77
Cariprazine + PlaceboAbbViePhase 3
77
CariprazineAbbViePhase 1
33
Omalizumab Injection [Xolair]NovartisPhase 1
33
RO7017773RochePhase 1
33
Placebo + RO7017773RochePhase 2
52
BalovaptanRochePhase 1
33
BalovaptanRochePhase 1
33
Balovaptan + EsomeprazoleRochePhase 1
33
Placebo + RG7314RochePhase 2
52
Placebo + RO5285119RochePhase 2
52
Balovaptan + PlaceboRochePhase 3
77
KarXT + KarX-EC + KarXT + KarX-EC Matching PlaceboBristol Myers SquibbPhase 3
76
AripiprazoleBristol Myers SquibbPhase 2
51
KarXT + KarX-EC + KarXT + KarX-EC Matching PlaceboBristol Myers SquibbPhase 3
76
Brexpiprazole + PlaceboLundbeckPhase 3
74
BrexpiprazoleLundbeckPhase 3
74